A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
Conditions:   HPV;   Oropharynx Cancer;   HPV-Related Carcinoma;   HPV-Related Malignancy;   HPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions:   Diagnostic Test: HPV ctDNA Assay;   Diagnostic Test: MRI Studies;   Behavioral: EORTC QLQ H&N 35 and C30;   Behavioral: MDADI-HN;   Behavioral: COST-FACIT
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 12, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments